FDA's health messages regulation
Reportedly, FDA has forwarded the final regulation to the Office of Management and Budget for approval. Agency proposed the rule to expand the allowable health claims for food products in August 1987 ("The Pink Sheet" Aug. 10, 1987, p. 6). Therapeutic, drug-like claims were excluded from the proposed rule.
You may also be interested in...
Seattle Genetics holds the award for fastest supplemental approval (11 days) and fastest new molecular entity approval (119 days) under the US FDA's RTOR program, according to the Pink Sheet's Performance Tracker.
Technology modernization efforts, the expansion of cloud-based submission capabilities, and the ongoing COVID-19 pandemic could serve as catalysts to broaden FDA’s Real-Time Oncology Review program beyond cancer therapeutics, Pfizer exec Richard Jahn says.
Former senior advisor to President Trump warns that failure to reform drug pricing practices has seriously handicapped prospects for reimbursing cell and gene therapy under existing US payer programs.